Raffaele Marolda

606 total citations
18 papers, 468 citations indexed

About

Raffaele Marolda is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Raffaele Marolda has authored 18 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Raffaele Marolda's work include Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Raffaele Marolda is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), CAR-T cell therapy research (4 papers) and Cutaneous Melanoma Detection and Management (4 papers). Raffaele Marolda collaborates with scholars based in Italy, United States and Switzerland. Raffaele Marolda's co-authors include Mario Santinami, Filiberto Belli, Natale Cascinelli, Giorgio Parmiani, Roberto Doci, Leandro Gennari, Federico Bozzetti, Maurizio Nava, Maurizio Vaglini and Giuseppe Fossati and has published in prestigious journals such as International Journal of Cancer, British journal of surgery and Diseases of the Colon & Rectum.

In The Last Decade

Raffaele Marolda

17 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele Marolda Italy 11 346 141 95 94 61 18 468
Samuel Bieligk United States 11 312 0.9× 75 0.5× 108 1.1× 53 0.6× 53 0.9× 13 473
W. Ruka Poland 5 349 1.0× 86 0.6× 109 1.1× 133 1.4× 102 1.7× 13 517
Yoshinari Matsuda Japan 11 132 0.4× 87 0.6× 81 0.9× 62 0.7× 89 1.5× 22 314
Jan P. Deroose Netherlands 11 219 0.6× 96 0.7× 87 0.9× 94 1.0× 125 2.0× 15 390
Elisabeth Hardy France 7 299 0.9× 54 0.4× 27 0.3× 163 1.7× 35 0.6× 10 470
Larsolof Hafström Sweden 8 227 0.7× 34 0.2× 117 1.2× 167 1.8× 179 2.9× 15 552
Kate Sandstrom United States 9 221 0.6× 256 1.8× 40 0.4× 99 1.1× 93 1.5× 13 435
H. Lurie Israel 11 294 0.8× 88 0.6× 57 0.6× 54 0.6× 115 1.9× 30 544
J L Ambrus United States 10 122 0.4× 230 1.6× 28 0.3× 90 1.0× 20 0.3× 21 432
B. Szynglarewicz Poland 11 225 0.7× 101 0.7× 96 1.0× 67 0.7× 36 0.6× 52 407

Countries citing papers authored by Raffaele Marolda

Since Specialization
Citations

This map shows the geographic impact of Raffaele Marolda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Marolda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Marolda more than expected).

Fields of papers citing papers by Raffaele Marolda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Marolda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Marolda. The network helps show where Raffaele Marolda may publish in the future.

Co-authorship network of co-authors of Raffaele Marolda

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Marolda. A scholar is included among the top collaborators of Raffaele Marolda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Marolda. Raffaele Marolda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cascinelli, Natale, Filiberto Belli, S Marchini, et al.. (1989). A Phase II Study of the Administration of Recombinant Interleukin 2 (rIL-2) Plus Lymphokine Activated Killer (LAK) Cells in Stage IV Melanoma Patients. Tumori Journal. 75(3). 233–244. 9 indexed citations
2.
Belli, Filiberto, S Marchini, Raffaele Marolda, et al.. (1989). A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patients.. PubMed. 75(3). 233–44. 2 indexed citations
3.
Gambacorti‐Passerini, Carlo, Marina Radrizzani, Raffaele Marolda, et al.. (1988). In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2. International Journal of Cancer. 41(5). 700–706. 26 indexed citations
4.
Vaglini, Maurizio, et al.. (1987). Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.. PubMed. 13(2). 127–9. 22 indexed citations
5.
Marolda, Raffaele, Filiberto Belli, Fabrizio Villani, et al.. (1987). A Phase I Study of Recombinant Interleukin 2 in Melanoma Patients. Toxicity and Clinical Effects. Tumori Journal. 73(6). 575–584. 11 indexed citations
6.
Cascinelli, Natale, Roberto Doci, Filiberto Belli, et al.. (1986). Evaluation of Toxic Effects following Administration of Monoclonal Antibody MBr1 in Patients with Breast Cancer. Tumori Journal. 72(3). 267–271. 5 indexed citations
7.
Balsari, Andrea, Raffaele Marolda, Carlo Gambacorti‐Passerini, et al.. (1986). Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. Cancer Immunology Immunotherapy. 21(2). 148–55. 23 indexed citations
8.
Cascinelli, N., Raffaele Marolda, Filiberto Belli, et al.. (1986). Regional non-nodal metastases of cutaneous melanoma.. PubMed. 12(2). 175–80. 78 indexed citations
9.
Vaglini, Maurizio, Salvatore Andreola, Filiberto Belli, et al.. (1985). Hyperthermic Antiblastic Perfusion in the Treatment of Cancer of the Extremities. Tumori Journal. 71(4). 355–359. 21 indexed citations
10.
Vaglini, Maurizio, Salvatore Andreola, Filiberto Belli, et al.. (1985). Limb-Salvage Procedure in Two Patients with Spindle Cell Carcinoma of the Lower Extremities using Isolation Perfusion. Tumori Journal. 71(3). 271–275. 4 indexed citations
11.
Cascinelli, Natale, Maurizio Vaglini, Maurizio Nava, et al.. (1984). Prognosis of skin melanoma with regional node metastases (stage II). Journal of Surgical Oncology. 25(4). 240–247. 74 indexed citations
12.
Taramelli, Donatella, Giuseppe Fossati, Andrea Balsari, Raffaele Marolda, & Giorgio Parmiani. (1984). The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA‐DR antigens on the tumor cells. International Journal of Cancer. 34(6). 797–806. 56 indexed citations
13.
Marolda, Raffaele, Arabella B. Tilden, Toru Abo, P. A. Dougherty, & Charles M. Balch. (1984). Characterization of a Subset of Human Natural Killer Cells That Express OKM1 But Lack HNK‐1 (Leu‐7) Antigens. Scandinavian Journal of Immunology. 20(3). 261–265. 9 indexed citations
14.
Bozzetti, Federico, Maurizio Nava, Rosaria Bufalino, et al.. (1983). Early local complications following colostomy closure in cancer patients. Diseases of the Colon & Rectum. 26(1). 25–29. 28 indexed citations
15.
Bonfanti, Giuliano, Federico Bozzetti, Roberto Doci, et al.. (1982). Results of extended surgery for cancer of the rectum and sigmoid. British journal of surgery. 69(6). 305–307. 82 indexed citations
16.
Rasponi, A, Alberto Costa, Rosaria Bufalino, et al.. (1981). Breast Cancer: Primary Tumor Characteristics Related to Lymph Node Involvement. Tumori Journal. 67(1). 19–26. 5 indexed citations
17.
Bonfanti, G., et al.. (1981). Microsphere angiography in hepatic artery infusion for cancer. European Journal of Nuclear Medicine and Molecular Imaging. 6(10). 473–6. 12 indexed citations
18.
Bozzetti, Federico, Roberto Doci, Raffaele Marolda, et al.. (1980). Surgical Treatment of Recurrences following Sphincter-Saving Procedures for Cancer of the Rectum. Tumori Journal. 66(6). 757–764. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Bieligk Breakdown of academic impact, for papers by W. Ruka Breakdown of academic impact, for papers by Yoshinari Matsuda Breakdown of academic impact, for papers by Jan P. Deroose Breakdown of academic impact, for papers by Elisabeth Hardy Breakdown of academic impact, for papers by Larsolof Hafström Breakdown of academic impact, for papers by Kate Sandstrom Breakdown of academic impact, for papers by H. Lurie Breakdown of academic impact, for papers by J L Ambrus Breakdown of academic impact, for papers by B. Szynglarewicz
Rankless by CCL
2026